Stay updated on DS-8201a in HER2 NSCLC Clinical Trial
Sign up to get notified when there's something new on the DS-8201a in HER2 NSCLC Clinical Trial page.

Latest updates to the DS-8201a in HER2 NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision: v3.4.1 has been added and Revision: v3.4.0 removed.SummaryDifference0.0%

- Check27 days agoChange DetectedShow glossary is now available by default, QC-related labels have capitalization tweaks (Last Update Submitted that Met QC Criteria), No FEAR Act Data is present, and the revision has been updated to v3.4.0.SummaryDifference0.2%

- Check41 days agoChange DetectedRevision history shows a new Revision: v3.3.4 added and the previous Revision: v3.3.3 removed.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded granular Locations listings for multiple sites (California, Colorado, Florida, Massachusetts, Michigan, Missouri, New York, Washington, Île-de-France Region, Rhne, Chiba, Osaka, Sunto-gun, Tokyo) and removed consolidated location blocks; the page revision is updated to v3.3.3.SummaryDifference1%

- Check91 days agoChange DetectedPubMed publications note updated to indicate automatic population from PubMed; revision tag updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to DS-8201a in HER2 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DS-8201a in HER2 NSCLC Clinical Trial page.